Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Alphabet's Gv Leads Funding In Gene Editing Company Verve Therapeutics
Venture Capital

Alphabet's Gv Leads Funding In Gene Editing Company Verve Therapeutics

by reuters.com posted 2weeks ago 6 views
May 7 - GV, Alphabet Inc's venture capital arm, led a $58.5 million investment to launch Verve Therapeutics, a new biotech focused on developing therapies that edit the human genome to treat heart diseases.

In this article